Skip to main content

Table 2 Baseline psychosocial data in patients with temporomandibular disorders pain resistant (TMD-R) or successful (TMD-S) to treatment, and in healthy controls. Data are presented as median (min–max)

From: Who is the patient with resistant myofascial temporomandibular disorders pain? A somatosensory, psychosocial, and genetic characterization

 

TMD-R

TMD-S

Control

p

 

n = 24

n = 24

n = 24

 

A-HADS (total)

8.0 (3-20)*

4.0 (0-19)

5.0 (1-13)

0.01

D-HADS (total)

8.0 (1-14)*

5.0 (0-10)

3.0 (0-8)

0.01

CSI (total)

50.0 (21-85)*

37.5 (12-80)#

25.0 (7-42)

0.01

PSS (total)

29.5 (13-40)*

21.0 (9-28)

21.50 (6-38)

0.03

PSQI (total)

10.0 (4-17)*

6.0 (0-14)#

4.0 (3-13)

0.01

PCS (total)

26.5 (10-49)*

19.5 (0-46)#

11.0 (0-23)

0.01

  1. HADS Hospital Anxiety (A) and Depression (D) Scale, CSI Central Sensitization Inventory, PSS Perceived Stress Scale, PSQI Pittsburgh Sleep Quality Index, PCS Pain Catastrophizing Scale
  2. Kruskall Wallis test (p) with Dunn’s test as postdoc: *p<0.05: significant differences between TMD-R and the other groups. #p<0.05: significant differences between TMD-S and Control group